Completed PHASE4 INTERVENTIONAL NCT00198198

Aripiprazole Treatment of Bipolar Depression

Open Label Pilot Study of Aripiprazole Treatment of Difficult to Treat Bipolar Depression

Sponsor: Indiana University School of Medicine

Updated 5 times since 2017 Last updated: Apr 3, 2007 Started: Aug 31, 2005 Completion: Nov 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Bipolar Depression and is currently completed. Indiana University School of Medicine leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indiana University School of Medicine

Data source: Indiana University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Indianapolis, United States